Beta2-adrenergic System and Training
NCT04616261 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-11-04
Summary
This project aims to examine the trainability of the beta2-adrenergic system with respect to the individual performance response
Conditions
- Healthy
Interventions
- BEHAVIORAL
-
Training
6 weeks of training
- DRUG
-
Formoterol
inhalation of 54 microg formoterol
- DRUG
-
inhalation of placebo
Sponsors & Collaborators
-
University of Copenhagen
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-10
- Primary Completion
- 2022-11-10
- Completion
- 2022-11-10
More Related Trials
-
Beta-2 Polymorphisms and Beta Receptor Selectivity
NCT00214318 ·Status: COMPLETED ·Phase: NA
-
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
NCT06263452 ·Status: RECRUITING ·Phase: PHASE4
-
Real World Assessment of Effects of Beta-blockers on Patients With Acute Coronary Syndrome
NCT03669991 ·Status: UNKNOWN
-
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT00288548 ·Status: UNKNOWN ·Phase: PHASE4
-
Analysis of Atropine and Propranolol Induced Changes
NCT00251602 ·Status: COMPLETED ·Phase: PHASE1
-
Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Atenolol Influence on Blood Pressure During Resistance Exercise
NCT01030016 ·Status: COMPLETED ·Phase: PHASE4
-
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
NCT04564365 ·Status: UNKNOWN
-
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
NCT01987219 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Beta-blockade for Improvement of Autonomic Activity
NCT00700466 ·Status: COMPLETED
-
Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
NCT01261065 ·Status: COMPLETED ·Phase: PHASE4
-
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
NCT07268170 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Beta2-mimetic and Central Nervous System
NCT02925130 ·Status: COMPLETED ·Phase: NA
-
Transplanted-like Heart in Critical Ill Patients
NCT01930669 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension
NCT01251146 ·Status: COMPLETED ·Phase: PHASE4
-
Effect Baroreflex Activation Therapy on the Carotid Body
NCT02210923 ·Status: UNKNOWN
-
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
NCT00925119 ·Status: TERMINATED ·Phase: PHASE4
-
Beta-blockers in i-PAH
NCT01246037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure
NCT02282618 ·Status: UNKNOWN
-
Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
NCT02516332 ·Status: COMPLETED ·Phase: NA
-
Hostility Reduction Program to Improve Autonomic Regulation of the Heart
NCT00365196 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Selective I(f)-Channel Blockade
NCT00865917 ·Status: UNKNOWN ·Phase: PHASE2
-
Assay to Measure Beta Blocker Adherence
NCT05251974 ·Status: TERMINATED
-
Dysautonomia in Patients Post COVID-19 Infection
NCT04716465 ·Status: UNKNOWN
-
pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure
NCT07029906 ·Status: RECRUITING ·Phase: NA